The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Hosted on MSN1mon
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decadesThe Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
9mon
HowStuffWorks on MSNSolving a Parabola Equation and Understanding ApplicationsThrough this equation, you can identify the vertex, axis of symmetry and the direction in which the parabola opens. Follow these steps to draw a parabola with the given equation: y = 2 2 − 4x ...
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
10d
MoneyWeek on MSNVertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...
Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results